Can tirzepatide help with PCOS — and is it safe to try?

Step 1: understand what the evidence currently shows

PCOS is a hormonal condition in which insulin resistance plays a central role for many women. Weight gain and difficulty losing weight are common, and excess body fat tends to worsen both insulin sensitivity and androgen levels, creating a cycle that is genuinely hard to break through diet and activity alone.

Tirzepatide (the active ingredient in Mounjaro) is a dual GIP and GLP-1 receptor agonist, meaning it activates two gut-hormone pathways involved in appetite regulation and blood-sugar control. In the SURMOUNT-1 trial, involving thousands of adults with obesity, participants on the highest dose lost around 20–21% of body weight on average over 72 weeks. The SURMOUNT-1 paper in the New England Journal of Medicine remains the primary evidence base for its weight-loss effects.

No large randomised controlled trial has yet looked at tirzepatide specifically in women with PCOS as its primary outcome. What exists is a growing body of smaller studies, case series and extrapolation from the broader weight-loss data. Clinically, the reasoning is coherent: meaningful weight loss consistently improves menstrual regularity, androgen markers and insulin sensitivity in PCOS, regardless of how that weight loss is achieved. If you want to understand whether Mounjaro will help your PCOS, the picture depends on how central weight and insulin resistance are to your presentation. That uncertainty matters, and any prescriber who says otherwise is overstating the data.

If you want a closer look at the research angle, this page on whether Mounjaro helps PCOS covers the clinical context in more depth.

Step 2: work through the safety and eligibility questions specific to PCOS

Before a prescriber considers tirzepatide for you, several PCOS-specific factors come into view.

Contraception: this is the most time-sensitive thing to get right. NHS guidance is clear that women taking oral contraceptives (the pill) should use an additional non-oral contraceptive method during the first four weeks of tirzepatide treatment and for four weeks after every dose increase, because gastric slowing may reduce pill absorption. NHS England's weight-management injections guidance covers this explicitly. Plan the conversation with your GP or prescriber before your first dose, not after.

Fertility intentions: if you are trying to conceive (or plan to in the near future) tirzepatide is not suitable. It is not recommended during pregnancy or breastfeeding, and effective contraception should be in place throughout treatment. For women with PCOS who hope pregnancy is on the horizon, this timing question is one of the first things a prescriber will ask. A quick check worth doing now: note where you are in any fertility treatment or family planning so you can describe it clearly in your consultation.

Other PCOS medications: metformin, combined oral contraceptives prescribed for hormone management, and spironolactone are all commonly used in PCOS. A prescriber needs to know about every medicine you take before approving tirzepatide. That interaction picture is why a thorough clinical assessment (not a tick-box questionnaire) matters here. More on taking Mounjaro alongside existing PCOS treatment is available if this applies to you.

BMI eligibility: the licensed threshold is a BMI of 30 or above, or 27 or above alongside a weight-related condition. PCOS with metabolic features can count as the qualifying condition at the lower threshold, though a prescriber makes that call individually.

Step 3: know what to discuss with a prescriber or specialist

PCOS is managed by a mix of clinicians: GPs, gynaecologists, endocrinologists and reproductive medicine specialists depending on what aspect is most active for you. Tirzepatide sits in the metabolic and weight-management lane, so the conversation often starts with your GP or a specialist prescribing service.

Things worth raising directly: how central insulin resistance is in your case, whether you have prediabetes or type 2 diabetes alongside PCOS, your current medications and how they interact, and your reproductive plans. A prescriber who understands PCOS will also want to know how your symptoms have responded to previous weight loss, even partial, since that gives a clearer picture of what tirzepatide's weight effect might achieve for you specifically.

At nume, every consultation is read personally by a GPhC-registered Independent Prescriber the same day. They review your health history, current medications and situation before any treatment decision is made. If you have questions before starting, our team is available seven days a week. For a broader look at how Mounjaro works as a treatment, the Mounjaro overview page covers mechanism, dosing schedule and what to expect. If cost is a factor in your thinking, Mounjaro pricing explains what a private prescription currently involves. Ready to take the next step? Start your free consultation and a prescriber will review whether tirzepatide is right for your situation.